Search Results - "Srivalli, Kale Mohana Raghava"

Drug nanocrystals: A way toward scale-up by Raghava Srivalli, Kale Mohana, Mishra, Brahmeshwar

“…Drug nanocrystals comprise unique drug delivery platforms playing a significantly important and distinctive role in drug delivery and as such, the industry and…”
Get full text

Overview of P-glycoprotein inhibitors: a rational outlook by Srivalli, Kale Mohana Raghava, Lakshmi, P. K.

“…P-glycoprotein (P-gp), a transmembrane permeability glycoprotein, is a member of ATP binding cassette (ABC) super family that functions specifically as a…”
Get full text

Drug nanocrystals: four basic prerequisites for formulation development and scale-up by Srivalli, Kale Mohana Raghava, Mishra, Brahmeshwar

“…Drug nanocrystals have been studied since the 1990s and there are already six therapeutic nanocrystal products on market and many more in clinical trials…”
Get more information

Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances by Srivalli, Kale Mohana Raghava, Mishra, Brahmeshwar

“…The purpose of this study was to improve the aqueous solubility, dissolution, and pharmacodynamic properties of a BCS class II drug, ezetimibe (Eze) by…”
Get full text

Preparation and pharmacodynamic assessment of ezetimibe nanocrystals: Effect of P-gp inhibitory stabilizer on particle size and oral absorption by Srivalli, Kale Mohana Raghava, Mishra, Brahmeshwar

“…[Display omitted] •Drug nanocrystals of ezetimibe were prepared by amalgamation using AA2G and TPGS.•AA2G has been successfully investigated as a nanocrystal…”
Get full text